Table 3.
Association between interpretive agreement and patient and case characteristics for all cases, and for Atypia cases (phase I diagnosis) only.
Case Characteristics | All Phase I interpretations | Interpreted as Atypia in Phase I a | ||||
---|---|---|---|---|---|---|
| ||||||
All Cases | Agreement with Phase I Interpretation | Atypia Cases a | Agreement with Phase I Interpretation | |||
| ||||||
N (%) | Rate (95% CI) | p-value | N (%) | Rate (95% CI) | p-value | |
Total | 240 (100.0) | 0.79 (0.77 - 0.81) | -- | 50 (100) | 0.53 (0.47 - 0.59) | -- |
| ||||||
Patient Age (yrs) b | ||||||
40-49 | 118 (49.2) | 0.79 (0.76 - 0.81) | 0.34 | 25 (50.0) | 0.52 (0.45 - 0.59) | 0.31 |
50-59 | 67 (27.9) | 0.78 (0.74 - 0.81) | 15 (30.0) | 0.50 (0.42 - 0.58) | ||
60-69 | 29 (12.1) | 0.82 (0.78 - 0.86) | 5 (10.0) | 0.62 (0.51 - 0.72) | ||
70+ | 26 (10.8) | 0.78 (0.73 - 0.82) | 5 (10.0) | 0.57 (0.45 - 0.67) | ||
Breast Densityc | ||||||
Low Density | 118 (49.2) | 0.81 (0.78 - 0.83) | 0.007 | 21 (42.0) | 0.51 (0.45 - 0.58) | 0.36 |
High Density | 122 (50.8) | 0.77 (0.75 - 0.79) | 29 (58.0) | 0.55 (0.48 - 0.62) | ||
Biopsy Type | ||||||
Core needle biopsy | 138 (57.5) | 0.78 (0.76 - 0.81) | 0.70 | 31 (62.0) | 0.56 (0.50 - 0.62) | 0.037 |
Excisional biopsy | 102 (42.5) | 0.79 (0.77 - 0.81) | 19 (38.0) | 0.48 (0.41 - 0.56) | ||
Average Number of Diagnoses per Cased | ||||||
1 | 14 (5.8) | 0.98 (0.95 - 0.99) | <0.001 | 0 (0.0) | (-) | 0.49 |
>1 and ≤2 | 194 (80.8) | 0.79 (0.77 - 0.81) | 39 (78.0) | 0.53 (0.47 - 0.59) | ||
>2 and ≤3 | 30 (12.5) | 0.73 (0.68 - 0.77) | 10 (20.0) | 0.56 (0.45 - 0.65) | ||
>3 | 2 (0.8) | 0.42 (0.24 - 0.61) | 1 (2.0) | 0.33 (0.10 - 0.68) |
Includes all interpretations considered to be Atypia by pathologists in Phase I.
The patient's age and type of biopsy information were provided to participants.
Low density (almost entirely fat or scattered fibroglandular densities) and high density (heterogeneously or extremely dense). Breast density information was not provided to participants.
Represents the number of diagnostic subtypes checked by pathologists in phase I per each interpretation, averaged at the level of the case.